Skip to main content

December 2024

Opportunity for PhD or M.Pharm, MS Pharm as Research Associate at NIPER

Research Associate I under a project entitled Peptide-metal chelator conjugates as potential therapeutic candidates for multifaceted amyloid-β toxicity in Alzheimers disease sponsored by Anusandhan National Research Foundation, GoI, New Delhi
Job for M.Pharm, MSc Life Sciences as IEC Coordinator at Tata Memorial Centre - ACTREC
PG in Science M.Pharm, M.Sc. in Life Science, Clinical Research Regulatory Affairs with 65% plus Diploma in Clinical Research and Pharmacovigilance Activity from recognized university. 1 years’ experience in Clinical research or IEC management is mandatory.
Vacancy for Ph.D, M.Pharm, MSc in food and nutritional Biotechnology division at NABI
PhD in Life Science, Food Science, Pharmacy, Biochemistry with at least three research paper in peer-reviewed research publications in science citation indexed journals in the area directly related to the project.
Interview for Pharma, Life Sciences candidates at Tata Memorial Hospital
Graduation in Science B.Pharm, Life Sciences, B.Sc., Biotech, Zoology, Botany, etc. with PG Diploma in Clinical Research is mandatory.
Walk in Drive for Injectable Oncology Plant at Amneal Pharmaceuticals - Freshers M.Pharm, B.Pharm, MSc can Apply
Candidates experience in Sterile Quality Assurance, covering QMS, Validation, IPQA, and related areas.
Alkem Laboratories Walk In Drive for D.Pharm, B.Pharm, M.Pharm in QC, QA, Production, Warehouse
RM, FG, Stability, Analytical Instrumentation-HPLC, UV and Dissolution. Handling of LIMS, Empower software, HPLC Waters SAP
Walk In Drive for M.Pharm, B.Pharm, MSc in QA, QC, Production, Microbiology at Indoco Remedies
Environment Monitoring, QMS, Routine and Non-Routine Analysis, PET, Sterility, BET and Water Testing. QMS, IPQA, AQA, Qualification, Process and Cleaning Validation, Aseptic Core Monitoring
Interview for M.Pharm, B.Pharm, MSc in QC, Packaging, Production, RM at BioMatrix Healthcare
BioMatrix Healthcare Private Limited, 100% export-oriented company headquartered at Ahmedabad, Gujarat, India, was established in 2007 with a thought of Supporting Life Worldwide.
Lynparza demonstrated clinically meaningful prolonged survival benefit in early breast cancer in OlympiA Phase III trial
Updated results from the OlympiA Phase III trial showed AstraZeneca and MSDs Lynparza olaparib demonstrated sustained, clinically meaningful improvements in overall survival , invasive disease-free survival IDFS and distant disease-free survival DDFS at six years for patients with germline BRCA-mutated gBRCAm HER2-negative high-risk early breast cancer.
IBRANCE® in combination with Standard-of-Care therapies extends survival by over 15 months
Pfizer Inc. and Alliance Foundation Trials, LLC announced results from the Phase 3 PATINA trial demonstrating that the addition of IBRANCE palbociclib to current standard-of-care first-line maintenance therapy following induction chemotherapy resulted in statistically significant and clinically meaningful improvement in progression-free survival by investigator assessment in patients with hormone receptor-positive